CBD treatment reverses key effects of fetal alcohol spectrum disorder in a mouse model
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Jan-2026 06:11 ET (14-Jan-2026 11:11 GMT/UTC)
Using a mouse model of fetal alcohol spectrum disorder, researchers found that early, chronic cannabidiol treatment normalized emotional behavior, reduced alcohol motivation, and modulated key brain biomarkers linked to addiction.
Published in Biomedicine & Pharmacotherapy, this study addresses the most common preventable cause of neurodevelopmental disability, for which no approved treatment currently exists. It shows that CBD reverses gut microbiota dysbiosis and restores gut–brain communication.
Tendons are strong – but not invincible. If repeatedly overloaded, for example during intense training, they can undergo gradual but harmful changes with debilitating pain.
A protein known as HIF1 is central to these changes, as researchers have now demonstrated in experiments in mice and with tendon tissue from humans.
Their findings open a path to new treatments that could act before the tissue is irreversibly damaged.
A new paper in Environmental Toxicology and Chemistry finds that common flea and tick control medications used in dogs and cats may pose a significant environmental risk to wild insects.
In a new study, terrestrial bacteria-infecting viruses were still able to infect their E. coli hosts in near-weightless “microgravity” conditions aboard the International Space Station, but the dynamics of virus-bacteria interactions differed from those observed on Earth. Phil Huss of the University of Wisconsin-Madison, U.S.A., and colleagues present these findings January 13th in the open-access journal PLOS Biology.
By studying genes that affect cuticle pigmentation in the laboratory fruit fly, researchers were able to identify new genes, mask and clu, that are involved in regulating dopamine levels in the brain. The findings offer new possibilities to restore in people disruptions in dopamine that have been associated with neurological and neuropsychiatric disorders, including addiction, depression, sleep disorders and schizophrenia.